Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate.
Richard Thomson-LuqueThomas C StablerKristin FürleJoana C SilvaClaudia DaubenbergerPublished in: Expert review of vaccines (2023)
Novel approaches to analyze breadth and magnitude of effector functions of MSP1-targeting antibodies in volunteers undergoing experimental vaccination and controlled human malaria infection will help to define correlates of protective immunity.